By Counterforce Health Team in Pemazyre (pemigatinib) —

How to Get Pemazyre (Pemigatinib) Covered by Blue Cross Blue Shield in North Carolina: Complete Guide with Forms, Appeals, and State Rights

Quick Answer: Getting Pemazyre Approved in North Carolina

Pemazyre (pemigatinib) requires prior authorization from Blue Cross Blue Shield of North Carolina for FGFR2+ cholangiocarcinoma or FGFR1+ myeloid/lymphoid neoplasms. Your fastest path: submit PA with molecular testing proof, prior therapy documentation, and medical necessity letter through the BCBSNC provider portal. If denied, you have 180 days to appeal internally, then 120 days for external review through Smart NC (1-855-408-1212). North Carolina law provides step therapy override rights and continuity of care protections for ongoing cancer treatment.

Table of Contents

Why North Carolina State Rules Matter

North Carolina's insurance laws provide specific protections that can help you get Pemazyre covered, even when Blue Cross Blue Shield initially denies your request. These state regulations work alongside your plan's policies to create additional pathways for approval.

Key North Carolina Protections:

  • Step therapy override rights under House Bill 821 (effective October 2015)
  • External review through Smart NC with binding decisions
  • Continuity of care laws for ongoing cancer treatment (up to 90 days)
  • Expedited review timelines for urgent oncology cases (72 hours)
Note: These protections apply to state-regulated plans. Self-funded employer plans (ERISA) may have different rules, though many voluntarily follow North Carolina standards.

Prior Authorization Requirements & Timelines

Coverage Criteria for Pemazyre

Blue Cross Blue Shield of North Carolina requires prior authorization for Pemazyre with these documented criteria:

Requirement Documentation Needed Where to Find It
FDA-approved indication FGFR2+ cholangiocarcinoma or FGFR1+ MLN FDA label
Molecular testing FGFR fusion/rearrangement report FDA-approved companion diagnostic
Prior therapy Evidence of previous systemic treatment Medical records, treatment notes
Staging documentation Unresectable/metastatic disease Imaging reports, pathology

Timeline Standards

Standard Review: 7 business days from complete submission Expedited Review: 72 hours for urgent cases (cancer progression, treatment delay risks) Renewal: Annual review required with response documentation

Counterforce Health helps clinicians streamline these submissions by automatically identifying the specific denial reasons and crafting targeted, evidence-backed appeals that align with BCBSNC's requirements.

Step Therapy Protections in North Carolina

North Carolina law requires insurers to provide a clear override process when step therapy requirements would delay appropriate care. For Pemazyre, this is particularly relevant since it's often a targeted therapy after other treatments have failed.

Override Criteria Under NC Law

Your step therapy override request must be expeditiously granted if:

  1. Prior failure: You've tried and failed the required step therapy drug(s)
  2. Contraindication: The step therapy drug is medically inappropriate
  3. Stable condition: You're already stable on Pemazyre
  4. Severe consequences: Delay would cause irreversible harm

Required Documentation

Your oncologist must provide:

  • Clinical notes documenting prior treatment failures or adverse effects
  • Medical rationale for Pemazyre specifically
  • Patient history and current disease status
  • Timeline showing urgency of treatment
From our advocates: We've seen step therapy overrides succeed when the medical necessity letter specifically references North Carolina General Statutes § 58-67-88, emphasizing that delays in targeted therapy for rare cancers can lead to disease progression and reduced treatment options.

Continuity of Care for Ongoing Treatment

If you're already receiving Pemazyre and your insurance changes or your provider leaves the BCBSNC network, North Carolina law protects your right to continue treatment.

Transition Coverage Rights

Duration: Up to 90 days for active cancer treatment Terminal illness: Coverage for remainder of life for terminal conditions Process: Submit BCBSNC Continuity of Care form within 45 days

Requirements:

  • Provider must accept previous reimbursement rates
  • Coverage subject to plan's utilization management
  • Must be for ongoing treatment relationship

Appeals Process: Internal to External Review

Level 1 Internal Appeal

Timeline: File within 180 days of denial notice Decision: 30 days standard, 72 hours expedited Submit to:

Level 2 Internal Appeal

Timeline: File within 60 days of Level 1 denial Process: May include peer-to-peer review between your oncologist and plan medical director Documentation: Include any new clinical information or guideline updates

External Review Through Smart NC

If both internal appeals are denied, North Carolina's external review provides an independent assessment.

Eligibility: State-regulated plans (not self-funded ERISA plans) Timeline: File within 120 days of final internal denial Decision: 45 days standard, 72 hours expedited Contact: Smart NC at 1-855-408-1212

The external review decision is binding – if approved, BCBSNC must provide coverage within 3 business days.

Practical Scripts & Documentation

Patient Phone Script for BCBSNC

"Hello, I'm calling about prior authorization for Pemazyre for my FGFR2-positive cholangiocarcinoma. My doctor submitted the request [date] and I need to check the status. My member ID is [number]. This is an FDA-approved targeted therapy for my specific mutation, and I've already failed [prior therapies]. Can you tell me what additional documentation might be needed?"

Medical Necessity Letter Template

Healthcare providers can reference this framework when writing appeals:

Key Elements to Include:

  • Patient's specific FGFR mutation and testing method
  • Previous therapies tried and reasons for failure/intolerance
  • Clinical rationale citing FDA approval and NCCN guidelines
  • Monitoring plan for potential side effects
  • Treatment goals and expected outcomes

Counterforce Health's platform automatically generates these medical necessity letters by ingesting your clinical notes and matching them against BCBSNC's specific coverage criteria, saving time while improving approval rates.

Formulary Exception Request

If Pemazyre is not on your plan's formulary:

  1. Submit exception request through BCBSNC provider portal
  2. Include clinical superiority argument – Pemazyre is the only FDA-approved option for your specific FGFR alteration
  3. Document contraindications to formulary alternatives
  4. Reference specialist recommendation from your oncologist

Coverage Limitations & ERISA Plans

Self-Funded Employer Plans

If your insurance is through a large employer, it may be self-funded (ERISA) and not subject to North Carolina state laws. However:

  • Many employers voluntarily adopt state standards
  • You still have internal appeal rights under federal ERISA law
  • External review may be available through the employer's chosen process

Verification

Check your insurance card or contact member services to confirm if your plan is state-regulated or self-funded.

Quick Reference: Contacts & Forms

BCBSNC Resources

North Carolina State Resources

  • Smart NC External Review: 1-855-408-1212
  • NC Department of Insurance: Medical Appeals
  • Consumer Assistance: Smart NC provides free help with appeals

Manufacturer Support

  • Incyte Patient Support: Connect with manufacturer programs for copay assistance and prior authorization support

FAQ: Common Questions

How long does BCBSNC prior authorization take for Pemazyre in North Carolina? Standard review is 7 business days from complete submission. Expedited review for urgent cases is 72 hours.

What if Pemazyre is not on my BCBSNC formulary? Submit a formulary exception request with clinical documentation showing medical necessity and lack of appropriate alternatives.

Can I request an expedited appeal in North Carolina? Yes, for urgent cases where treatment delay would jeopardize health. Both internal appeals and external review through Smart NC offer expedited timelines.

Does step therapy apply if I've failed treatments outside North Carolina? Yes, documented treatment failures from other states should be accepted. Include complete medical records and treatment summaries.

What happens if Smart NC external review approves my Pemazyre coverage? The decision is binding. BCBSNC must provide coverage within 3 business days of the approval decision.

Are there copay assistance programs for Pemazyre? Yes, contact Incyte patient support for manufacturer copay cards and foundation grant programs that may help with out-of-pocket costs.

What if my employer plan is self-funded (ERISA)? North Carolina state laws may not apply, but you still have federal appeal rights. Many employers voluntarily follow state standards for external review.

Can I continue Pemazyre if my doctor leaves the BCBSNC network? Yes, North Carolina continuity of care laws provide up to 90 days of transition coverage for ongoing cancer treatment.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on your specific plan and medical circumstances. Always consult with your healthcare provider and insurance company for personalized guidance.

For additional support with complex prior authorization challenges, Counterforce Health specializes in turning insurance denials into successful appeals by leveraging payer-specific requirements and evidence-based documentation strategies.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.